These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26593695)

  • 61. Orofacial granulomatosis: clinical signs of different pathologies.
    Troiano G; Dioguardi M; Giannatempo G; Laino L; Testa NF; Cocchi R; De Lillo A; Lo Muzio L
    Med Princ Pract; 2015; 24(2):117-22. PubMed ID: 25592641
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical behaviour and long-term therapeutic response in orofacial granulomatosis patients treated with intralesional triamcinolone acetonide injections alone or in combination with topical pimecrolimus 1%.
    Mignogna MD; Pollio A; Leuci S; Ruoppo E; Fortuna G
    J Oral Pathol Med; 2013 Jan; 42(1):73-81. PubMed ID: 22784292
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Symptomatic Oral Crohn's Disease in an Adolescent.
    Schmitz BA; Unkel JH
    J Dent Child (Chic); 2018 May; 85(2):66-69. PubMed ID: 30345956
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Orofacial granulomatosis associated with Crohn's disease.
    Kim SK; Lee ES
    Ann Dermatol; 2010 May; 22(2):203-5. PubMed ID: 20548915
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease.
    Ewe K; Press AG; Singe CC; Stufler M; Ueberschaer B; Hommel G; Meyer zum Büschenfelde KH
    Gastroenterology; 1993 Aug; 105(2):367-72. PubMed ID: 8335191
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Low-level laser as a complementary therapy in orofacial granulomatosis management: a case report.
    Jácome-Santos H; Resende RG; Silva AMB; Cruz AF; Tanos de Lacerda SH; Mesquita RA; Tanos de Lacerda JC
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Jul; 128(1):e1-e5. PubMed ID: 30987889
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Using Ustekinumab to Treat Crohn's Disease-Related Orofacial Granulomatosis: Two Birds, One Stone.
    Gilmore R; Li Wai Suen CFD; Elliott T; De Cruz P; Srinivasan A
    Inflamm Bowel Dis; 2020 Jul; 26(8):e79-e80. PubMed ID: 32448910
    [No Abstract]   [Full Text] [Related]  

  • 68. Onset and progression of clinical manifestations of orofacial granulomatosis.
    Al Johani K; Moles DR; Hodgson T; Porter SR; Fedele S
    Oral Dis; 2009 Apr; 15(3):214-9. PubMed ID: 19222765
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lip impressions: a new method for monitoring morphological changes in orofacial granulomatosis.
    Chiandussi S; Tappuni AR; Watson TF; White A; Escudier MP; Sanderson JD; Challacombe SJ
    Oral Dis; 2007 Jan; 13(1):93-8. PubMed ID: 17241437
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
    Papay P; Reinisch W; Ho E; Gratzer C; Lissner D; Herkner H; Riss S; Dejaco C; Miehsler W; Vogelsang H; Novacek G
    Am J Gastroenterol; 2010 May; 105(5):1158-64. PubMed ID: 20010925
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Orofacial granulomatosis: review on aetiology and pathogenesis.
    Tilakaratne WM; Freysdottir J; Fortune F
    J Oral Pathol Med; 2008 Apr; 37(4):191-5. PubMed ID: 18321344
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term outcome of patients with Crohn's disease who respond to azathioprine.
    Camus M; Seksik P; Bourrier A; Nion-Larmurier I; Sokol H; Baumer P; Beaugerie L; Cosnes J
    Clin Gastroenterol Hepatol; 2013 Apr; 11(4):389-94. PubMed ID: 23142207
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate].
    Hafraoui S; Dewit O; Marteau P; Cosnes J; Colombel JF; Modigliani R; Cortot A; Lémann M
    Gastroenterol Clin Biol; 2002 Jan; 26(1):17-22. PubMed ID: 11938035
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Orofacial granulomatosis of the lower lip and cheek: report of a case.
    Shams MG; Motamedi MH; Azizi T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Oct; 104(4):e42-4. PubMed ID: 17703966
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Orofacial granulomatosis in children--a challenge for diagnosis and treatment.
    Kolho KL; Heiskanen K; Verkasalo M; Pitkäranta A
    Int J Pediatr Otorhinolaryngol; 2011 Jun; 75(6):864-7. PubMed ID: 21458863
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Successful Mercaptopurine Usage despite Azathioprine-Induced Pancreatitis in Paediatric Crohn's Disease.
    Gallego-Gutiérrez S; Navas-López VM; Kolorz M; Bartosova L; Lukac K; Luque-Pérez S; Núñez-Caro L; García-Galán P; Fernández-Crehuet FG; Blasco-Alonso J; Serrano-Nieto MJ; Sierra-Salinas C
    J Crohns Colitis; 2015 Aug; 9(8):676-9. PubMed ID: 25968582
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease Recurrence.
    Ferrante M; Papamichael K; Duricova D; D'Haens G; Vermeire S; Archavlis E; Rutgeerts P; Bortlik M; Mantzaris G; Van Assche G;
    J Crohns Colitis; 2015 Aug; 9(8):617-24. PubMed ID: 25926532
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Are pancreatic autoantibodies associated with azathioprine-induced pancreatitis in Crohn's disease?
    Weersma RK; Batstra MR; Kleibeuker JH; van Dullemen HM
    JOP; 2008 May; 9(3):283-9. PubMed ID: 18469440
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Economic impact of combination therapy with infliximab plus azathioprine for drug-refractory Crohn's disease: a cost-effectiveness analysis.
    Saito S; Shimizu U; Nan Z; Mandai N; Yokoyama J; Terajima K; Akazawa K
    J Crohns Colitis; 2013 Mar; 7(2):167-74. PubMed ID: 22626508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.